ALC - Alcon AG - Stock Price & Dividends

Alcon AG is a global leader in the eye care industry, dedicated to researching, developing, manufacturing, distributing, and selling a wide range of innovative products for eye care professionals and their patients worldwide.

The company's Surgical segment is a one-stop-shop for ophthalmic surgeons, offering a comprehensive portfolio of equipment, instrumentation, and diagnostics. This includes intraocular lenses (IOLs), implantables, and consumables such as viscoelastics, surgical solutions, and incisional instruments. The segment's cataract products are particularly noteworthy, featuring cutting-edge technologies like the Centurion vision system, LenSx laser system, and NGENUITY 3D visualization system. Additionally, Alcon offers a range of vitreoretinal products, including constellation vision systems, procedure packs, and medical grade vitreous tamponades, as well as refractive surgery products like WaveLight lasers and Contoura Vision for LASIK treatment.

Alcon's implantable products are designed to improve patient outcomes, including AcrySof IQ products, which offer advanced technology IOLs for the correction of presbyopia and astigmatism during cataract surgery. The company's EX-PRESS glaucoma filtration device is another example of its commitment to innovative solutions for eye care professionals.

In addition to its Surgical segment, Alcon's Vision Care segment provides a diverse range of products for everyday eye care, including daily disposable, reusable, and color-enhancing contact lenses. The company's ocular health products address common issues like dry eye, glaucoma, and ocular allergies, while its ocular vitamins and redness relievers promote overall eye health.

With a rich history dating back to 1945, Alcon AG has evolved to become a trusted partner for eye care professionals worldwide. Headquartered in Geneva, Switzerland, the company continues to drive innovation and excellence in the eye care industry.